NCT00392197View on ClinicalTrials.gov

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

1 or 2 times a day, p.o., 6 - 24mg a day

Trial Locations (5)

Unknown

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Touhoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY